LISA SATTER to Janus Kinases
This is a "connection" page, showing publications LISA SATTER has written about Janus Kinases.
Connection Strength
0.935
-
Human diseases caused by impaired signal transducer and activator of transcription and Janus kinase signaling. Curr Opin Pediatr. 2019 12; 31(6):843-850.
Score: 0.325
-
JAK/STAT proteins and their biological impact on NK cell development and function. Mol Immunol. 2019 11; 115:21-30.
Score: 0.306
-
Jakinibs for the treatment of immune dysregulation in patients with gain-of-function signal transducer and activator of transcription 1 (STAT1) or STAT3 mutations. J Allergy Clin Immunol. 2018 11; 142(5):1665-1669.
Score: 0.148
-
Ruxolitinib reverses dysregulated T helper cell responses and controls autoimmunity caused by a novel signal transducer and activator of transcription 1 (STAT1) gain-of-function mutation. J Allergy Clin Immunol. 2017 May; 139(5):1629-1640.e2.
Score: 0.067
-
JAK/STAT defects and immune dysregulation, and guiding therapeutic choices. Immunol Rev. 2024 03; 322(1):311-328.
Score: 0.054
-
Ruxolitinib partially reverses functional natural killer cell deficiency in patients with signal transducer and activator of transcription 1 (STAT1) gain-of-function mutations. J Allergy Clin Immunol. 2018 06; 141(6):2142-2155.e5.
Score: 0.035